Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco School of Medicine, San Francisco, California.
Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco School of Medicine, San Francisco, California.
Womens Health Issues. 2022 Sep-Oct;32(5):477-483. doi: 10.1016/j.whi.2022.05.001. Epub 2022 May 17.
Telehealth use rapidly increased during the COVID-19 pandemic, including for contraceptive care (e.g., counseling and method provision). This study explored providers' experiences with contraceptive care via telehealth.
We conducted a survey with open-ended responses among contraceptive providers across the United States. The study population included physicians, nurse practitioners, health educators, and other health professionals (n = 546). Data were collected from April 10, 2020, to January 29, 2021. We conducted qualitative content analysis of the open-ended responses.
Providers highlighted the benefits of telehealth, including continuing access to contraceptive services and accommodating patients who faced challenges attending in-person contraceptive visits. Providers at school-based health centers reported telehealth allowed them to reach young people while schools were closed. However, many providers noted a lack of patient awareness about the availability of telehealth services and disparities in access to technology. Providers felt there was less personal connection in virtual contraceptive counseling, noted challenges with confidentiality, and expressed concern about the inability to provide the full range of contraceptive methods through telehealth alone.
The pandemic significantly impacted contraceptive health care delivery. Telehealth has sustained access to contraception in important ways, but has been accompanied by various challenges, including technological access and confidentiality. As hybrid models of care evolve, it is important to assess how telehealth can play a role in providing contraceptive care while addressing its barriers.
在 COVID-19 大流行期间,远程医疗的使用迅速增加,包括避孕护理(例如咨询和方法提供)。本研究探讨了提供者通过远程医疗进行避孕护理的经验。
我们在美国各地的避孕提供者中进行了一项带有开放式回答的调查。研究人群包括医生、护士从业者、健康教育者和其他健康专业人员(n=546)。数据于 2020 年 4 月 10 日至 2021 年 1 月 29 日收集。我们对开放式回答进行了定性内容分析。
提供者强调了远程医疗的好处,包括继续获得避孕服务和为那些在面对面避孕访问中面临挑战的患者提供便利。学校保健中心的提供者报告说,远程医疗使他们能够在学校关闭期间接触到年轻人。然而,许多提供者指出患者对远程医疗服务的可用性缺乏认识,并且在获得技术方面存在差异。提供者认为虚拟避孕咨询中的个人联系较少,注意到保密性方面的挑战,并对仅通过远程医疗无法提供全套避孕方法表示关注。
大流行对避孕保健服务的提供产生了重大影响。远程医疗在重要方面维持了避孕的获取,但也伴随着各种挑战,包括技术获取和保密性。随着混合护理模式的发展,评估远程医疗在提供避孕护理方面可以发挥作用,同时解决其障碍非常重要。